Abbott Laboratories News
Pfizer Snags Hospira in $16 Billion Deal
Pfizer seeking growth with injectables and biosimilars therapies.
Asian Stocks Mixed After Wall Street Slide
Asian stocks were mixed Friday after Wall Street slid and Japan's central bank surprised markets by putting off possible additional stimulus
US economy struggles at start of election year WASHINGTON (AP) — It was not a great start for the U.S. economy. With consumers and businesses turning cautious, the U.S. struggled to grow in the first three months of a presidential election year that is shining the spotlight on the economy's fitful
Facebook and St. Jude Medical Surge, GNC and AbbVie Skid
Facebook and St. Jude Medical climb in Wall Street trading, while GNC Holdings and AbbVie slump
Abbott Labs to Spend $19.3 Billion to Buy St. Jude Medical
Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical Inc. in a cash-stock deal that aims to strengthen the medical device maker's share of the market for cardiovascular care
Drug Maker Doesn't Want Public to Think 'Popping Vicodin is Trendy or Cool'
A line of popular and controversial t-shirts are the focus of a lawsuit in which drug maker AbbVie Inc. is saying they don't want the public to think "popping Vicodin is a cool 'in' thing to do." Biopharmaceutical company AbbVie is suing Kitson, which runs trendy fashion boutiques under the company
Belviq Hits Market: Diet Pills Then and Now
With more than 36 percent of American adults now classified as obese according to the Centers for Disease Control and Prevention, and the numbers still climbing, doctors are clamoring for more pharmaceuticals to treat their patients. Last year, the Federal Drug Administration obliged by approving
7 Richest Snitches: Time to Rat Out Your Boss?
Ever dream of getting rich by blowing the whistle on your boss? People have—most recently Bradley Birkenfeld, the ex-banker whom the IRS paid a record $104 million for ratting out his former banking bosses who had helped U.S. clients to hide money in Swiss accounts. Have any other blowers cashed in
Sears Chief, Other CEOs Continue High-Flying Ways
It's good to be the king--or in this case, CEO of Sears. At the same time the troubled retailer is shutting stores and laying off "associates," it is paying $800,000 a year to waft Chief Executive Louis J. D'Ambrosio between Philadelphia, where he lives, and Chicago, where he works, by private jet.